癌症治疗中的CRBN-PROTACs:从机械洞察到临床应用
Riya Thapa1, Asif Ahmad Bhat1, Gaurav Gupta2,3
1Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Dehradun, India.
Chemical biology & drug design
|November 4, 2024
概括
脑蛋白 (CRBN) E3结合酶是癌症治疗的关键标. 依赖CRBN的PROTACs可以利用细胞.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 脑 (CRBN) 是一种E3泛素酶,对癌症中蛋白质降解至关重要.
- 不调节的蛋白质降解有助于癌症的进展.
研究的目的:
- 审查CRBN依赖的PROTAC (CRBN-PROTAC) 的机制.
- 总结一下CRBN-PROTAC用于癌症治疗的应用中的最新进展.
- 讨论CRBN-PROTACs在瘤学中的未来潜力.
主要方法:
- 审查关于CRBN和PROTAC技术的现有文献.
- 对CRBN-PROTACs的临床前和临床数据的分析.
- 探索CRBN在癌症生物学和治疗向中的作用.
主要成果:
- 通过ubiquitin-proteasome系统,CRBN-PROTACs可以选择性地诱导目标蛋白质的降解.
- 在血液恶性瘤和固体瘤中观察到有希望的临床前疗效.
- 与传统抑制剂相比,CRBN-PROTACs具有克服药物耐药性的潜力.
结论:
- CRBN-PROTACs代表了癌症的新疗法策略.
- 通过CRBN-PROTAC,我们可以更好地了解CRBN在癌症中的作用.
- 基于CRBN的方法可以作为患者分层和治疗反应的生物标志物.
关键词:
编号:CRBN 编号:CRBN 编号:CRBN 编号:CRBN 编号:CRBN 编号:CRBN 编号:CRBN头脑中的黄金E3 无处不在的合酶这就是 PROTACs.癌症治疗疗法 癌症治疗药物耐药性 耐药性 药物耐药性固体瘤是一种固体瘤.有针对性的蛋白质降解降解.无处不在的蛋白酶体系统.更多相关视频
07:40Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis
Published on: March 20, 2021
16.5K
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
7.2K
相关概念视频
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K